ArticleFrontiers in immunology2026
Transient expansion of peripheral Lambda-expressing plasma cells represents a distinctive phenotype associated with SFTSV infection.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with a high fatality rate. The mechanism of SFTS is widely recognized to be closely associated with dysregulated host immune responses. However, comprehensive assessments of peripheral immune patterns in SFTS remains limited. This study aimed to characterize the profiles of peripheral immune responses and identify unique immune subsets involved in the pathogenesis of SFTS. Methods: Twenty-four patients diagnosed with SFTS were enrolled in this study. Flow cytometric analysis was employed to determine the percentages, absolute counts, and immunophenotypes of immune cells. An external validation cohort of eighteen patients was used to validate the Lambda-expressing plasma cells expansion in SFTS. Results: Patients with SFTS exhibited markedly increased activation and exhaustion of CD4 Conclusions: This study is the first to identify an expansion of peripheral transient Lambda-expressing plasma cells in SFTS cases, representing a distinctive immunological hallmark of SFTSV infection. These findings provide valuable insights into the pathogenesis of SFTS and may facilitate the development of improved diagnostic and therapeutic approaches for patients with SFTS.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.